Intima-media thickness of the carotid arteries is related to serum osteoprotegerin levels in healthy postmenopausal women

Neurological Research

Volumn 26, Issue 6, 2004, Pages 658-661

  Erdogan, Bulent ^a   Asian, Erdogan ^a   Bagis, Tayfun ^a   Gokcel, Adnan ^a   Erkanli, Serkan ^a   Bavbek, Murad ^a   Altinors, Nur ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Atherosclerosis; Carotid artery; Intima media thickness; Osteoprotegerin; Postmenopause

Indexed keywords

APOLIPOPROTEIN A1; OSTEOPROTEGERIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; BONE MASS; CAROTID ARTERY; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; INTIMA; LABORATORY TEST; MAJOR CLINICAL STUDY; OSTEOCLAST; PATHOGENESIS; PLAQUE FORMING CELL; POSTMENOPAUSE; RISK FACTOR; ULTRASOUND;

CAROTID ARTERIES; CROSS-SECTIONAL STUDIES; FEMALE; GLYCOPROTEINS; HUMANS; MIDDLE AGED; OSTEOPROTEGERIN; POSTMENOPAUSE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; STATISTICS, NONPARAMETRIC; TUNICA INTIMA;

EID: 12544253103     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164104225014157     Document Type: Article

References (27)

1. Adams RD, Victor M. Principles of Neurology, New York: McGraw-Hill, 1993: pp. 669-748
2. Broderick J, Brott T, Kothari R, et al. The Greater Cincinnati/ Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks. Stroke 1998; 29: 415-421
3. Gorelick PB, Sacco RL, Smith DB, et al. Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA 1999; 281: 1112-1120
4. Hofbauer LC, Dunstan CR, Speisberg TC, et al. Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines. Biochem Biophys Res Com 1998; 250: 776-781
5. Yasuda H, Shima N, Nakagawa N, et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and Osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 1998; 39: 1329-1337
6. Tan KB, Harrop J, Reddy M, et al. Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells. Gene 1997; 204: 35-46
7. Collin-Osdoby P, Rothe L, Anderson F, et al. Receptor activator of NF-kappa B and Osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis. J Biol Chem 2001; 276: 20659-20672
8. Bucay N, Sarosi I, Dunstan CR, et al. Osteoprotegeriç-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998; 12: 1260-1268
9. Hofbauer LC, Shui C, Riggs BL, et al. Effects of immunosuppressants on receptor activator of NF-kappaB ligand and Osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells. Biochem Biophys Res Commun 2001; 280: 334-339
10. Malyankar UM, Scatena M, Suchland KL, et al. Osteoprotegerin is an alpha vbeta 3-induced, NF-kappa B-dependent survival factor for endothelial cells. J Biol Chem 2000; 275: 20959-20962
11. Colditz GA, Willett WC, Stampfer MJ, et al. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987; 316: 1105-1110
12. Craven TE, Ryu JE, Espeland MA, et al. Evaluation of the association between carotid artery atherosclerosis and coronary artery stenosis. A case control study. Circulation 1990; 82: 1230-1242
13. Kallikazaros I, Tsioufis C, Sideris S, et al. Carotid artery disease as a marker for the presence of severe coronary artery disease in patients evaluated for chest pain. Stroke 1999; 30: 1002-1007
14. O'Leary DH, Polak JF, Kronmal RA, et al. Carotid artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999; 340: 14-22
15. Hillen T, Nieczaj R, Munzberg H, et al. Carotid atherosclerosis, vascular risk profile and mortality in a population-based sample of functionally healthy elderly subjects: the Berlin ageing study. J Int Med 2000; 247: 679-688
16. Touboul PJ, Elbaz A, Koller C, et al. Common carotid artery intimamedia thickness and brain infarction. GENIC case-control study. Circulation 2000; 102: 213-218
17. Chambless LE, Folsom AR, Clegg LX, et al. Carotid wall thickness is predictive of incident clinical stroke. The atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 2000; 151: 478-487
18. Browner WS, Lui LY, Cummings SR. Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women. J Clin Endocrinol Metab 2001; 86: 631-637
19. Bonithon-Kopp C, Touboul PJ, Berr C, et al. Relation of intimamedia thickness to atherosclerosis plaques in carotid arteries. The vascular aging (EVA) study. Arterioscler Thromb Vasc Biol 1996; 16: 310-316
20. Jono S, Ikari Y, Shioi A, et al. Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation 2002; 106: 1192-1194
21. O'Leary DH, Polak JF, Wolfson SK, et al. on behalf of the CHS Collaborative Research Group. Use of sonography to evaluate carotid atherosclerosis in the elderly: the Cardiovascular Health Study. Stroke 1991; 22: 1115-1163
22. Salonen R, Seppanen K, Rauramaa R, et al. Determinants of carotid intima-media thickness: a population-based ultrasonography study in Eastern Finnish men. J Intern Med 1991; 229: 225-231
23. Bots ML, Hofman A, de Bruyn AM, et al. Isolated systolic hypertension and vessel wall thickness of the carotid artery: the Rotterdam Elderly Study. Arterioscler Thromb 1993; 13: 64-69
24. Baron YM, Galea R, Brincat M. Carotid artery wall changes in estrogen-treated and -untreated postmenopausal women. Obstet Gynecol 1998; 91: 982-986
25. Schoppet M, Preissner KT, Hofbauer LC. RANK ligand and osteoprotegerin. Paracrine regulators of bone metabolism and vascular function. Arterioscler Thromb Vasc Biol 2002; 22: 549-553
26. Brandstrom H, Stiger F, Lind L, et al. A single nucleotid polymorphism in the promoter region of the human gene of osteoprotegerin is related to vascular morphology and function. Biochem Biophys Res Commun 2002; 293: 13-17
27. Schoppet M, Sattler AM, Schaefer JR, et al. Increased osteoprotegerin serum levels in men with coronary artery disease. J Clin Endocrinol Metab 2003; 88: 1024-1028